The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo

BACKGROUND: Combination therapy is a key strategy for minimizing drug resistance, a common problem in cancer therapy. The microtubule-depolymerizing agent vincristine is widely used in the treatment of acute leukemia. In order to decrease toxicity and chemoresistance of vincristine, this study will...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Chao, Min-Wu, Lai, Mei-Jung, Liou, Jing-Ping, Chang, Ya-Ling, Wang, Jing-Chi, Pan, Shiow-Lin, Teng, Che-Ming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504084/
https://ncbi.nlm.nih.gov/pubmed/26156322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0176-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados